LINDSEY LACKEY: Open Payments
NPI 1841974128 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 74 payments from 12 companies in 2025. Trend: 2023 $44 · 2024 $293 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $691 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $156 |
| Janssen Biotech, Inc. | 6 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $121 |
| Aimmune Therapeutics, Inc. | 6 | $108 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| Madrigal Pharmaceuticals | 3 | $65 |
| QOL Medical, LLC | 3 | $61 |
| Celltrion USA Inc. | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
Products named: SKYRIZI, RINVOQ, XIFAXAN, TREMFYA, ENTYVIO, ZENPEP, MAVYRET, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
